Scarica l'app Stockscreener
6.99
0.71%
-0.04
Precedente Chiudi:
$7.03
Aprire:
$7.01
Volume 24 ore:
10,518
Relative Volume:
0.14
Capitalizzazione di mercato:
$403.77M
Reddito:
$154.57M
Utile/perdita netta:
$15.07M
Rapporto P/E:
25.89
EPS:
0.27
Flusso di cassa netto:
$10.92M
1 W Prestazione:
-1.97%
1M Prestazione:
-1.13%
6M Prestazione:
+0.43%
1 anno Prestazione:
+14.99%
Intervallo 1D:
$6.975
$7.01
Intervallo di 1 settimana:
$6.631
$7.2371
Portata 52W:
$5.54
$9.155
Kamada Ltd Stock (KMDA) Company Profile
Confronta KMDA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
7.00 | 405.50M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
118.93 | 52.03B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.43 | 45.40B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.535 | 42.13B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.56 | 34.19B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
482.62 | 20.88B | 3.08B | 1.24B | 1.07B | 25.61 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Iniziato | The Benchmark Company | Buy |
| 2024-07-03 | Iniziato | Stifel | Buy |
| 2018-02-02 | Iniziato | Chardan Capital Markets | Buy |
Kamada Ltd Borsa (KMDA) Ultime notizie
HC Wainwright Has Bearish Outlook for Kamada FY2026 Earnings - Defense World
Sidoti Csr Comments on Kamada’s Q1 Earnings (NASDAQ:KMDA) - Defense World
Kamada Ltd. Shareholders Approve Key Resolutions at Annual Meeting - TipRanks
H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus - Investing.com Nigeria
Why Is Kamada Stock Trading lower todayKamada (NASDAQ:KMDA) - Benzinga
Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN
Kamada to Discontinue Phase 3 Trial of Inhaled AAT: Shares Fall - marketscreener.com
Kamada discontinues Phase 3 inhaled AAT clinical trial - TipRanks
Kamada reiterates FY25 revenue guidance $178M-$182M - TipRanks
Kamada (KMDA) Halts Phase 3 Trial of Inhaled AAT for Alpha-1 Ant - GuruFocus
Kamada Discontinues Phase 3 Inhaled AAT Trial, Projects Growth in 2026 - TipRanks
Kamada reiterates 2025 FY revenue guidance of $178M-$182M - marketscreener.com
Kamada Reiterates 2025 FY Revenue Guidance Of $178M-$182M - TradingView
Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial By Investing.com - Investing.com Canada
Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial - Investing.com
Kamada (NASDAQ: KMDA) drops inhaled AAT study, reaffirms $178M-$182M 2025 revenue - Stock Titan
Shareholders May Not Be So Generous With Kamada Ltd.'s (TLV:KMDA) CEO Compensation And Here's Why - simplywall.st
Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving Average – Time to Sell? - Defense World
Technical Reactions to KMDA Trends in Macro Strategies - news.stocktradersdaily.com
Kamada updates proxy statement ahead of annual shareholder meeting By Investing.com - Investing.com Australia
Kamada updates proxy statement ahead of annual shareholder meeting - Investing.com
Is Kamada Ltd. stock positioned well for digital economyJuly 2025 Patterns & Weekly Consistent Profit Watchlists - BỘ NỘI VỤ
Is Kamada Ltd. stock affected by interest rate hikesWeekly Investment Report & Free Weekly Chart Analysis and Trade Guides - BỘ NỘI VỤ
Will Kamada Ltd. stock see insider buyingQuarterly Portfolio Summary & Precise Trade Entry Recommendations - moha.gov.vn
Kamada Ltd. (NASDAQ:KMDA) Q3 2025 Earnings Call Transcript - MSN
Kamada (NASDAQ:KMDA) Stock Passes Below 200 Day Moving AverageTime to Sell? - MarketBeat
Is Kamada's Dual Focus On Plasma Capacity And Clinical Trials Unlocking New Opportunities? - RTTNews
Kamada Ltd. (KMDA) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Tangible book value per share of Kamada Ltd – TASE:KMDA - TradingView
Kamada's (TLV:KMDA) Performance Is Even Better Than Its Earnings Suggest - simplywall.st
How supply chain issues affect Kamada Ltd. stockFed Meeting & Capital Efficient Trading Techniques - newser.com
Why Kamada Ltd. stock is favored by pension funds2025 Market Overview & Weekly Market Pulse Updates - newser.com
Is Kamada Ltd. stock resilient to inflationJuly 2025 Opening Moves & Expert Curated Trade Setups - newser.com
Using Ichimoku Cloud for Kamada Ltd. technicalsEarnings Performance Report & Technical Pattern Alert System - newser.com
How Kamada Ltd. stock compares to growth peersGlobal Markets & High Conviction Trade Alerts - newser.com
Is Kamada Ltd. stock in correction or buying zone2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
Why Kamada Ltd. stock is in analyst buy zoneWeekly Market Report & Weekly Top Gainers Alerts - newser.com
Risk adjusted return profile for Kamada Ltd. analyzedJuly 2025 Rallies & Low Drawdown Trading Strategies - newser.com
How Kamada Ltd. stock performs in stagflationTrade Risk Report & Free Technical Pattern Based Buy Signals - newser.com
Kamada Ltd. Reports Strong Growth Amid Challenges - MSN
Is Kamada Ltd. stock attractive after correction2025 Major Catalysts & Safe Capital Growth Trade Ideas - newser.com
Kamada Reports Strongest Quarter For The Year In Q3, With Over 30% Profitability Increase Year-Over-Year - NewMediaWire
Price action breakdown for Kamada Ltd.2025 Analyst Calls & Precise Buy Zone Tips - newser.com
Kamada Ltd Azioni (KMDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.84%
0.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):